202 related articles for article (PubMed ID: 38256198)
1. Recent Advances in the Diagnosis, Pathogenesis, and Management of Myxoinflammatory Fibroblastic Sarcoma.
Nishio J; Nakayama S; Aoki M
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256198
[TBL] [Abstract][Full Text] [Related]
2. Deep sequencing of myxoinflammatory fibroblastic sarcoma.
Arbajian E; Hofvander J; Magnusson L; Mertens F
Genes Chromosomes Cancer; 2020 May; 59(5):309-317. PubMed ID: 31898851
[TBL] [Abstract][Full Text] [Related]
3. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
[TBL] [Abstract][Full Text] [Related]
4. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
[TBL] [Abstract][Full Text] [Related]
5. Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.
Antonescu CR; Zhang L; Nielsen GP; Rosenberg AE; Dal Cin P; Fletcher CD
Genes Chromosomes Cancer; 2011 Oct; 50(10):757-64. PubMed ID: 21717526
[TBL] [Abstract][Full Text] [Related]
6. RNA-sequencing of myxoinflammatory fibroblastic sarcomas reveals a novel SND1::BRAF fusion and 3 different molecular aberrations with the potential to upregulate the TEAD1 gene including SEC23IP::VGLL3 and TEAD1::MRTFB gene fusions.
Klubíčková N; Agaimy A; Hájková V; Ptáková N; Grossmann P; Šteiner P; Michal M; Michal M
Virchows Arch; 2022 Oct; 481(4):613-620. PubMed ID: 35776191
[TBL] [Abstract][Full Text] [Related]
7. The t(1;10)(p22;q24) TGFBR3/MGEA5 Translocation in Pleomorphic Hyalinizing Angiectatic Tumor, Myxoinflammatory Fibroblastic Sarcoma, and Hemosiderotic Fibrolipomatous Tumor.
Liu H; Sukov WR; Ro JY
Arch Pathol Lab Med; 2019 Feb; 143(2):212-221. PubMed ID: 29979612
[TBL] [Abstract][Full Text] [Related]
8. Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases.
Suster D; Michal M; Huang H; Ronen S; Springborn S; Debiec-Rychter M; Billings SD; Goldblum JR; Rubin BP; Michal M; Suster S; Mackinnon AC
Mod Pathol; 2020 Dec; 33(12):2520-2533. PubMed ID: 32514165
[TBL] [Abstract][Full Text] [Related]
9. Myxoinflammatory fibroblastic sarcoma: morphologic and genetic updates.
Ieremia E; Thway K
Arch Pathol Lab Med; 2014 Oct; 138(10):1406-11. PubMed ID: 25268202
[TBL] [Abstract][Full Text] [Related]
10. Recurrent YAP1::MAML2 fusions in "nodular necrotizing" variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases.
Perret R; Tallegas M; Velasco V; Soubeyran I; Coindre JM; Azmani R; Baud J; Bacle G; De Pinieux G; Le Loarer F
Mod Pathol; 2022 Oct; 35(10):1398-1404. PubMed ID: 35546636
[TBL] [Abstract][Full Text] [Related]
11. Unexpected Clinical Outcome for Myxoinflammatory Fibroblastic Sarcoma, When Should They Be Considered High Grade?
Sparkman BK; Nguyen TVV; Smith SC; Bear HD
J Investig Med High Impact Case Rep; 2023; 11():23247096231205344. PubMed ID: 37840277
[TBL] [Abstract][Full Text] [Related]
12. Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions.
Hallor KH; Sciot R; Staaf J; Heidenblad M; Rydholm A; Bauer HC; Aström K; Domanski HA; Meis JM; Kindblom LG; Panagopoulos I; Mandahl N; Mertens F
J Pathol; 2009 Apr; 217(5):716-27. PubMed ID: 19199331
[TBL] [Abstract][Full Text] [Related]
13. Cytopathology of myxoinflammatory fibroblastic sarcoma: a series of eight cases and review of the literature.
Wangsiricharoen S; Ali SZ; Wakely PE
J Am Soc Cytopathol; 2021; 10(3):310-320. PubMed ID: 33431307
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic hyalinizing angiectatic tumor revisited: all tumors manifest typical morphologic features of myxoinflammatory fibroblastic sarcoma, further suggesting 2 morphologic variants of a single entity.
Michal M; Kazakov DV; Hadravský L; Agaimy A; Švajdler M; Kuroda N; Michal M
Ann Diagn Pathol; 2016 Feb; 20():40-3. PubMed ID: 26626209
[TBL] [Abstract][Full Text] [Related]
15. Myxoinflammatory fibroblastic sarcoma of the scalp: aggressive behavior at a rare, nonextremity site.
Vroobel K; Miah A; Fisher C; Thway K
Int J Surg Pathol; 2015 Jun; 23(4):292-7. PubMed ID: 25673633
[TBL] [Abstract][Full Text] [Related]
16. Myxoinflammatory Fibroblastic Sarcoma of Eyeball in an Infant: A Rare Presentation.
Jain E; Kini L; Alaggio R; Ranganathan S
Int J Surg Pathol; 2020 May; 28(3):306-309. PubMed ID: 31594432
[TBL] [Abstract][Full Text] [Related]
17. Hemosiderotic Fibrolipomatous Tumor, Pleomorphic Hyalinizing Angiectatic Tumor, and Myxoinflammatory Fibroblastic Sarcoma: Related or Not?
Boland JM; Folpe AL
Adv Anat Pathol; 2017 Sep; 24(5):268-277. PubMed ID: 28375867
[TBL] [Abstract][Full Text] [Related]
18. TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms.
Carter JM; Sukov WR; Montgomery E; Goldblum JR; Billings SD; Fritchie KJ; Folpe AL
Am J Surg Pathol; 2014 Sep; 38(9):1182-992. PubMed ID: 24705316
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a spontaneously transformed cell line (JU-PI) from a myxoinflammatory fibroblastic sarcoma.
Fagerstedt KW; Salonen T; Zhao F; Kytölä S; Böhling T; Andersson LC
Tumour Biol; 2018 May; 40(5):1010428318777936. PubMed ID: 29788803
[TBL] [Abstract][Full Text] [Related]
20. Myxoinflammatory fibroblastic sarcoma: a case report.
Ertener O; Tuna B; Akçali O; Yörükoğlu K
Acta Orthop Traumatol Turc; 2013; 47(6):436-9. PubMed ID: 24509225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
